Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 17,159 | 18,615 | 15,125 | 18,314 | 14,926 |
| Gross Profit | 17,159 | 18,615 | 15,125 | 18,314 | 14,926 |
| Operating Expenses | 29,011 | 29,868 | 33,511 | 37,207 | 39,453 |
| Operating Income | -11,852 | -11,253 | -18,386 | -18,893 | -24,527 |
| Interest Expense | 3,316 | 3,083 | 2,387 | 1,618 | 1,714 |
| Other Income | 2,084 | 2,422 | 2,105 | 2,285 | 2,292 |
| Pre-tax Income | -13,084 | -11,914 | -18,668 | -18,226 | -23,949 |
| Income Tax | 7 | 24 | 32 | 29 | -1,305 |
| Net Income Continuous | -13,091 | -11,938 | -18,700 | -18,255 | -22,644 |
| Net Income | $-13,091 | $-11,938 | $-18,700 | $-18,255 | $-22,644 |
| EPS Basic Total Ops | -0.45 | -0.42 | -0.88 | -0.85 | -1.06 |
| EPS Basic Continuous Ops | -0.45 | -0.42 | -0.87 | -0.85 | -1.06 |
| EPS Diluted Total Ops | -0.45 | -0.42 | -0.88 | -0.85 | -1.06 |
| EPS Diluted Continuous Ops | -0.45 | -0.42 | -0.87 | -0.85 | -1.06 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.42 | -0.87 | -0.85 | -1.06 |
| EBITDA(a) | $-10,341 | $-10,003 | $-18,060 | $-17,670 | $-22,508 |